Buell Jennifer 4
4 · Protagenic Therapeutics, Inc.\new · Filed Mar 29, 2024
Insider Transaction Report
Form 4
Buell Jennifer
Director
Transactions
- Award
PTIX Common stock Options
2024-03-25$1.74/sh+75,000$130,500→ 75,000 totalExercise: $1.74Exp: 2034-03-25→ PTIX Common Stock, Par Value $0.0001 (75,000 underlying)
Footnotes (1)
- [F1]50,000 of the options are fully-exerciseable on March 25, 2026. The other 25,000 of the options are exercisable on and after the date upon which the company consummates a corporate partnership, if that occurs before December 31, 2026. If the company does not enter into a corporate partnership before December 31, 2026, then those 25,000 options are never exercisable.